Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.
ALASMARI, A; Houghton, J; GREENWOOD, B; HEYMANN, D; EDWARDS, P; LARSON, H; Assiri, A; Ben-Rached, F; Pain, A; BEHRENS, R; BUSTINDUY, A;
2021
Tropical Medicine and International Health, (2021).26 4 10.1111/tmi.13546.
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Li, X; MUKANDAVIRE, C; Cucunubá, ZM; Echeverria Londono, S; ABBAS, K; Clapham, HE; JIT, M; Johnson, HL; Papadopoulos, T; VYNNYCKY, E; Brisson, M; Carter, ED; CLARK, A; De Villiers, MJ; Eilertson, K; Ferrari, MJ; Gamkrelidze, I; Gaythorpe, KA M; Grassly, NC; Hallett, TB; Hinsley, W; Jackson, ML; Jean, K; Karachaliou, A; KLEPAC, P; ... Vaccine Impact Modelling Consortium,
2021
The Lancet, (2021).397 10272 10.1016/S0140-6736(20)32657-X.
Transmission dynamics and control measures of COVID-19 outbreak in China: a modelling study.
Zhang, X-S; VYNNYCKY, E; Charlett, A; De Angelis, D; Chen, Z; Liu, W;
2021
Scientific reports, (2021).11 1 10.1038/s41598-021-81985-z.
Durable natural killer cell responses after heterologous two-dose Ebola vaccination.
Wagstaffe, HR; Susannini, G; Thiébaut, R; Richert, L; Lévy, Y; Bockstal, V; Stoop, JN; Luhn, K; Douoguih, M; Riley, EM; Lacabaratz, C; GOODIER, MR;
2021
npj Vaccines, (2021).6 1 10.1038/s41541-021-00280-0.
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe, K; Abbas, K; Huber, J; Karachaliou, A; Thakkar, N; Woodruff, K; Li, X; Echeverria-Londono, S; VIMC Working Group on COVID-19 Impact on Vaccine P,; Ferrari, M; Jackson, M; McCarthy, K; Perkins, A; Trotter, C; JIT, M;
2021
medRxiv (2021). 10.1101/2021.01.25.21250489.
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... CORTIS-01 Study Team,
2021
The Lancet. Infectious diseases, (2021).21 3 10.1016/S1473-3099(20)30914-2.
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio, M; Lhomme, E; Kieh, M; Beavogui, AH; Kennedy, SB; Doumbia, S; Leigh, B; Sow, SO; Diallo, A; Fusco, D; Kirchoff, M; Termote, M; Vatrinet, R; Wentworth, D; Esperou, H; Lane, HC; Pierson, J; Watson-Jones, D; Roy, C; D'Ortenzio, E; GREENWOOD, B; Chêne, G; Richert, L; Neaton, JD; Yazdanpanah, Y; ... PREVAC study team,
2021
Trials, (2021).22 1 10.1186/s13063-021-05035-9.
Optimising Vaccine Dose in Inoculation against SARS-CoV-2, a Multi-Factor Optimisation Modelling Study to Maximise Vaccine Safety and Efficacy.
BENEST, J; RHODES, S; QUAIFE, M; Evans, TG; WHITE, RG;
2021
Vaccines, (2021).9 2 10.3390/vaccines9020078.
Regulation of the human NK cell compartment by pathogens and vaccines.
GOODIER, MR; Riley, EM;
2021
Clinical & Translational Immunology, (2021).10 1 10.1002/cti2.1244.
RISK11 signature scores for the biomarker-guided tuberculosis preventive therapy (CORTIS) randomised controlled trial.
Scriba, TJ; Fiore-Gartland, A; Penn-Nicholson, A; Mulenga, H; Kimbung Mbandi, S; Borate, B; Mendelsohn, SC; Hadley, K; Hikuam, C; Kaskar, M; Musvosvi, M; Bilek, N; Self, S; SUMNER, T; WHITE, RG; Erasmus, M; Jaxa, L; Raphela, R; Innes, C; Brumskine, W; Hiemstra, A; Malherbe, ST; Hassan-Moosa, R; Tameris, M; Walzl, G; ... Hatherill, M.
2021
, University of Cape Town (2021).